Aprepitant in the Management of Immune Checkpoint Inhibitors Pruritus in Solid Cancer Patients

NCT06931119 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Pruritus

Interventions

DRUG: EMEND® (EE mend) (aprepitant) capsules (80mg +125mg) Marketing Authorization Holder and Importer: Merck Sharp & Dohme (Israel-1996) Company Ltd.

Sponsor

Rabin Medical Center